Histone Cell Cycle Regulation Defective Homolog A (HIRA)

[Edit]

DGCR1; TUP1; TUPLE1; DiGeorge Critical Region Gene 1; TUP1-like enhancer of split protein 1

Histone Cell Cycle Regulation Defective Homolog A (HIRA)
HIRA encodes a histone chaperone that preferentially places the variant histone H3.3 in nucleosomes. Orthologs of this gene in yeast, flies, and plants are necessary for the formation of transcriptionally silent heterochomatin. This gene plays an important role in the formation of the senescence-associated heterochromatin foci. These foci likely mediate the irreversible cell cycle changes that occur in senescent cells. It is considered the primary candidate gene in some haploinsufficiency syndromes such as DiGeorge syndrome, and insufficient production of the gene may disrupt normal embryonic development.The protein product of the TUPLE1 gene contains WD40 domains, motifs thought to be involved in protein-protein interactions.Expressed at high levels in kidney, pancreas and skeletal muscle and at lower levels in brain, heart, liver, lung, and placenta.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Histone Cell Cycle Regulation Defective Homolog A (HIRA) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Histone Cell Cycle Regulation Defective Homolog A (HIRA) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Histone Cell Cycle Regulation Defective Homolog A (HIRA) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Histone Cell Cycle Regulation Defective Homolog A (HIRA) CLIA Kit Customized Service Offer
n/a ELISA Kit for Histone Cell Cycle Regulation Defective Homolog A (HIRA) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Histone Cell Cycle Regulation Defective Homolog A (HIRA) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Histone Cell Cycle Regulation Defective Homolog A (HIRA) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Histone Cell Cycle Regulation Defective Homolog A (HIRA) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Histone Cell Cycle Regulation Defective Homolog A (HIRA) CLIA Kit Customized Service Offer
n/a ELISA Kit for Histone Cell Cycle Regulation Defective Homolog A (HIRA) ELISA Kit Customized Service Offer
  1. "A human homolog of the S. cerevisiae HIR1 and HIR2 transcriptional repressors cloned from the DiGeorge syndrome critical region."Hum. Mol. Genet. 4:791-799(1995) [PubMed] [Europe PMC] [Abstract]
  2. "Structural organization of the WD repeat protein-encoding gene HIRA in the DiGeorge syndrome critical region of human chromosome 22."Genome Res. 6:43-50(1996) [PubMed] [Europe PMC] [Abstract]
  3. "A genome annotation-driven approach to cloning the human ORFeome."Genome Biol. 5:R84.1-R84.11(2004) [PubMed] [Europe PMC] [Abstract]
  4. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  5. "Isolation of a putative transcriptional regulator from the region of 22q11 deleted in DiGeorge syndrome, Shprintzen syndrome and familial congenital heart disease."Hum. Mol. Genet. 2:2099-2107(1993) [PubMed] [Europe PMC] [Abstract]
  6. "The murine homologue of HIRA, a DiGeorge syndrome candidate gene, is expressed in embryonic structures affected in human CATCH22 patients."Hum. Mol. Genet. 6:247-258(1997) [PubMed] [Europe PMC] [Abstract]
  7. "Core histones and HIRIP3, a novel histone-binding protein, directly interact with WD repeat protein HIRA."Mol. Cell. Biol. 18:5546-5556(1998) [PubMed] [Europe PMC] [Abstract]
  8. "HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression."Mol. Cell. Biol. 21:1854-1865(2001) [PubMed] [Europe PMC] [Abstract]
  9. "Coupling of DNA synthesis and histone synthesis in S phase independent of cyclin/cdk2 activity."Mol. Cell. Biol. 22:7459-7472(2002) [PubMed] [Europe PMC] [Abstract]
  10. "Structure and function of the conserved core of histone deposition protein Asf1."Curr. Biol. 13:2148-2158(2003) [PubMed] [Europe PMC] [Abstract]
  11. "Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis."Cell 116:51-61(2004) [PubMed] [Europe PMC] [Abstract]
  12. "Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA."Dev. Cell 8:19-30(2005) [PubMed] [Europe PMC] [Abstract]
  13. "Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates."J. Biol. Chem. 280:5004-5012(2005) [PubMed] [Europe PMC] [Abstract]
  14. "A quantitative atlas of mitotic phosphorylation."Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]
  15. "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."Anal. Chem. 81:4493-4501(2009) [PubMed] [Europe PMC] [Abstract]
  16. "Human UBN1 is an ortholog of yeast Hpc2p and has an essential role in the HIRA/ASF1a chromatin-remodeling pathway in senescent cells."Mol. Cell. Biol. 29:758-770(2009) [PubMed] [Europe PMC] [Abstract]
  17. "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract]
  18. "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
  19. "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
  20. "Structure of a human ASF1a-HIRA complex and insights into specificity of histone chaperone complex assembly."Nat. Struct. Mol. Biol. 13:921-929(2006) [PubMed] [Europe PMC] [Abstract]